Literature DB >> 23792095

C6-Deoxy coelenterazine analogues as an efficient substrate for glow luminescence reaction of nanoKAZ: the mutated catalytic 19 kDa component of Oplophorus luciferase.

Satoshi Inouye1, Jun-ichi Sato, Yuiko Sahara-Miura, Suguru Yoshida, Hajime Kurakata, Takamitsu Hosoya.   

Abstract

The codon-optimized gene for the mutated 19 kDa protein (nanoKAZ), which is the catalytic component of Oplophorus luciferase, was expressed in Escherichia coli cells and the recombinant protein was highly purified. The secretory expression of nanoKAZ from CHO-K1 cells was performed by fusing the secretory signal peptide sequence of Gaussia luciferase to the amino-terminus of nanoKAZ. The substrate specificity for the purified nanoKAZ and the nanoKAZ secreted into the cultured medium was determined, indicating that bis-coelenterazine (bis-CTZ) and newly synthesized 6h-f-coelenterazine (6h-f-CTZ) are an efficient substrate for the glow luminescence reaction of nanoKAZ.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  19kOLase; CTZ; Codon-optimized gene; Coelenterazine; FWHM; Furimazine; GLase; Gaussia; Gaussia luciferase; I(max); Reporter assay; coelenterazine; full width at half maximum; maximum intensity of luminescence; nanoKAZ; relative light units; rlu; the catalytic 19kDa protein of Oplophorus luciferase; the mutated 19kOLase

Mesh:

Substances:

Year:  2013        PMID: 23792095     DOI: 10.1016/j.bbrc.2013.06.026

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Development and Applications of Bioluminescent and Chemiluminescent Reporters and Biosensors.

Authors:  Hsien-Wei Yeh; Hui-Wang Ai
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2019-02-20       Impact factor: 10.745

2.  Multiplex quadruple bioluminescent assay system.

Authors:  Genta Kamiya; Nobuo Kitada; Shojiro Maki; Sung Bae Kim
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

3.  Development of Recombinant Infectious Hepatitis E Virus Harboring the nanoKAZ Gene and Its Application in Drug Screening.

Authors:  Putu Prathiwi Primadharsini; Shigeo Nagashima; Takashi Nishiyama; Masaharu Takahashi; Kazumoto Murata; Hiroaki Okamoto
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

4.  Luciferase-Specific Coelenterazine Analogues for Optical Contamination-Free Bioassays.

Authors:  Ryo Nishihara; Masahiro Abe; Shigeru Nishiyama; Daniel Citterio; Koji Suzuki; Sung Bae Kim
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

5.  Bioluminescent Sensors for Ca++ Flux Imaging and the Introduction of a New Intensity-Based Ca++ Sensor.

Authors:  Jie Yang; Carl Hirschie Johnson
Journal:  Front Bioeng Biotechnol       Date:  2021-10-27

6.  Host-Dependent Producibility of Recombinant Cypridina noctiluca Luciferase With Glycosylation Defects.

Authors:  Yasuo Mitani; Rie Yasuno; Kiyohito Kihira; KwiMi Chung; Nobutaka Mitsuda; Shusei Kanie; Azusa Tomioka; Hiroyuki Kaji; Yoshihiro Ohmiya
Journal:  Front Bioeng Biotechnol       Date:  2022-02-07

7.  Reverse mutants of the catalytic 19 kDa mutant protein (nanoKAZ/nanoLuc) from Oplophorus luciferase with coelenterazine as preferred substrate.

Authors:  Satoshi Inouye; Jun-Ichi Sato; Yuiko Sahara-Miura; Yuri Tomabechi; Yuto Sumida; Shun-Ichi Sekine; Mikako Shirouzu; Takamitsu Hosoya
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

8.  Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.

Authors:  Rie Sonamoto; Isao Kii; Yuka Koike; Yuto Sumida; Tomoe Kato-Sumida; Yukiko Okuno; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

9.  Red-shifted luciferase-luciferin pairs for enhanced bioluminescence imaging.

Authors:  Hsien-Wei Yeh; Omran Karmach; Ao Ji; David Carter; Manuela M Martins-Green; Hui-Wang Ai
Journal:  Nat Methods       Date:  2017-09-04       Impact factor: 28.547

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.